Neurofibromatosis and associated tumour suppressor genes

Pathology Research and Practice

Volumn 192, Issue 7, 1996, Pages 647-657

  Zwarthoff, E C ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Band 4.1 superfamily proteins; GTPase activating protein; NF1; NF2; Tumour suppressor gene

Indexed keywords

NEUROFIBROMIN; RAS PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; BENIGN TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CELL TYPE; CHROMOSOME 17Q; CHROMOSOME 22; CYTOSKELETON; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; PENETRANCE; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0029784764     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80086-0     Document Type: Article

References (109)

1. National Institutes of Health Consensus Statement on Acoustic Neuroma (1992) Neurofibromatosis Research Newsletter 8: 1-7
2. NIH Consensus Development Statement on Neurofibromatosis (1988) Archives of Neurology 45: 575-578
3. Abernathy CR, Colman SD, Kousseff BG, Wallace MR (1994) Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3′ end of the gene. Hum Mutat 3: 347-352
4. Algrain M, Arpin M, Louvard D (1993) Wizardry at the cell cortex. Current Biology 3; 451-454
5. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M (1993) Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120: 129-139
6. Andersen LB, Fountain JW, Gutmann DH, Tarle SA, Glover TW, Dracopoli NC, Housman DE, Collins FS (1993) Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 3: 118-121
7. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63: 851-859
8. Bar-Sagi D, Feramisco JR (1985) Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42: 841-848
9. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715
10. BerrymanM, Franck Z, Bretscher A (1993) Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105: 1025-1043
11. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR et al. (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6: 185-192
12. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ (1994) Analysis of mutations in the SCH gene in schwannomas. Genes Chromosom Cancer 11: 7-14
13. Bollag G, McCormick F (1992) NF is enough of GAP. Nature 356: 663-664
14. Bollag G, McCormick F, Clark R (1993) Tubulin inhibits RAS GAP activity. EMBO J 12: 1923-1927
15. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689
16. Bourn D, Carter SA, Evans DG, Goodship J, Coakham H, Strachan T (1994) A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 55: 69-73
17. Bourn D, Carter SA, Mason S, Gareth D, Evans R, Strachan T (1994) Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 3: 813-816
18. Bourn D, Evans G, Mason S, Tekes S, Trueman L, Strachan T (1995) Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet 95: 572-574
19. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8: 1019-1029
20. Burridge K, Connel L (1993) Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interaction. Cell Motil 3: 405-417
21. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell Pet al. (1990). A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62: 193-201
22. Collins FC (1992) Positional cloning: Let's not call it reverse anymore. Nature Genetics 1: 3-4
23. DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR (1992) Abnormal regulation of mammalian p21 ras contributes to malignant tumor growth in von recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273
24. Den Bakker MA, Riegman PH, Hekman RA, Boersma W, Janssen PJ, van der Kwast TH, Zwarthoff EC (1995) The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 10: 757-763
25. Den Bakker MA, Tascilar M, Riegman PHJ, Hekman ACP, Boersma W, Jansen PJA, De Jong TAW, Hendriks W, Van der Kwast TH, Zwarthoff EC (1995) The NF2 protein co-localizes with elements of the cytoskeleton. Am J Hum Pathol 147: 1339-1349
26. Dublin S, Riccardi VM, Stephens K (1995) Methods for rapid detection of a recurrent nonsense mutation and documentation of phenotyic features in neurofibromatosis type 1 patients. Hum Mutat 5: 81-85
27. Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53: 305-313
28. Egan SE, Weinberg RA (1993) The pathway to signal achievement. Nature 365: 781-783
29. Englefield P, Foulkes WD, Campbell IG (1994) Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Br J Cancer 70: 905-907
30. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84: 603-618
31. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromarosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29: 841-846
32. Fahsold R, Habash T, Trautmann U, Haustein A, Pfeiffer RA (1995) Familial reciprocal translocation t(17; 19) (q11.2; q13.2) associated with neurofibromatosis type 1, including one patient with non-hodgkin lymphoma and an additional t(14; 20) in b lymphocytes. Hum Genet 96: 65-69
33. Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2: 404-414
34. Goldgar DE, Green P, Parry DM, Mulvihill JJ (1989) Multipoint linkage analysis in neurofibromatosis type 1: an international collaboration. Am J Human Genetics 44: 6-12
35. Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, Jacks T, Wood DL, Jove R, Collins FS (1993) Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 19: 265-274
36. Grifa A, Piemontese MR, Melchionda S, Origone P, Zelante L, Coviello D, Fratta G, Dallapiccola B, Balestrazzi P, Ajmar F, Gasparini P (1995) Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant. Clin Genet 47: 281-284
37. Gutmann DH, Cole JL, Stone WJ, Ponder BA, Collins FS (1994) Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosom Cancer 10: 55-58
38. Heim RA, Kammorgan L, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silverman LM, Luce MC (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4: 975-981
39. Hoang-Xuan K, Merel P, Vega F, Hugot JP, Cornu P, Delattre JY, Poisson M, Thomas G, Delattre O (1995) Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 60: 478-481
40. Huson SM (1994) Neurofibromatosis 1: A Clinical and Genetic Overview. In: Huson SM, Hughes RAC, (Eds) The Neurofibromatoses, pp 160-203. Chapman & Hall Medical, London
41. Huson SM (1994) Neurofibromatosis. Historical Perspective, Classification and Diagnostic Criteria. In: Huson SM, Hughes RAC (Eds) The Neurofibromatoses, pp 1-22. Chapman & Hall Medical, London
42. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER (1994) Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 3: 347-350
43. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA (1994) Tumour predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 7: 353-361
44. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh Vet al. (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3: 413-419
45. Johnson MR, DeClue JE, Felzmann S, Vass WC, Xu G, White R, Lowy DR (1994) Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 14 641-645
46. Kayes LM, Burke W, Riccardi VM, Bennett R, Ehrlich P, Rubenstein A, Stephens K (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 54: 424-436
47. Kluwe L, Pulst SM, Koppen J, Mautner VF (1995) A 163-bp deletion at the c-terminus of the schwannomin gene associated with variable phenotypes of neurofibromatosis type 2. Hum Genet 95: 443-446
48. Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci USA 90: 10914-10921
49. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 829-823
50. Lazaro C, Ravella A, Gaona A, Volpini V, Estivill X (1994) Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. N Engl J Med 331: 1403-1407
51. Legius E, Dierick H, Wu R, Hall BK, Marynen P, Cassiman JJ, Glover TW (1994) TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosom Cancer 10: 250-255
52. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3: 122-126
53. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N et al. (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54: 1022-1029
54. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M et al. (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281
55. Li Y, O'Connel P, Huntsman Breidenbach H, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R, Viskochil D (1995) Genomic Organization of the Neurofibromatosis 1 Gene (NF1). Genomics 25: 9-18
56. Luna EJ (1991) Molecular links between the cytoskeleton and membranes. Curr Opin Cell Biol 3: 120-126
57. Lutchman M, Rouleau GA (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3t3 cells. Cancer Res 55: 2270-2274
58. MaCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J (1993) DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree. Jama 270: 2316-2320
59. MacCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J (1993) DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree. Jama 270: 2316-2320
60. MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio MP, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R et al. (1994) Mutational analysis of patients with neurofibromatosis. 2. Am J Hum Genet 55: 314-320
61. Marchuk DA, Collins FS (1994) Molecular Genetics of Neurofibromatosis 1. In: Huson SM, Hughes RAC (Eds) The Neurofibromatoses, pp 23-49. Chapman & Hall Medical, London
62. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon RM et al. (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63: 843-849
63. Martuza RL, Seizinger BR, Jacoby LB (1988) The molecular biology of human glial tumors. Trends in Neuroscience 11: 22-27
64. Merel P, Hoangxuan K, Sanson M, Moreauaubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G (1995) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Gene Chromosome Cancer 13: 211-216
65. Merel P, Khe HX, Sanson M, Bijlsma E, Rouleau G, Laurent-Puig P, Pulst S, Baser M, Lenoir G, Sterkers JM et al. (1995) Screening for germ-line mutations in the NF2 gene. Genes Chromosom Cancer 12: 117-127
66. Meyers RM, Fischer SG, Lerman LS, Maniatis T (1985) Nearly all single base substituions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Research 13: 3131-3145
67. Nijssen PC, Deprez RH, Tijssen CC, Hagemeijer A, Arnoldus EP, Teepen JL, Holl R, Niermeyer MF (1994) Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neurosurg Psychiatry 57: 1245-1248
68. O'Connell P, Leach R, Cawthon RM, Culver M, Stevens J, Viskochil D, Fournier RE, Rich DC, Ledbetter DH, White R (1989) Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science 244: 1087-1088
69. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U (1995) Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95: 347-351
70. Parry DM, Eldridge R, Kaiser-Kupfer M, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Medical Genetics 52: 450-461
71. Purandare SM, Davidson HR, Lanyon WG, Connor JM (1994) A novel insertional mutation of a single base in exon 34 of the neurofibromatosis-1 gene. Hum Mutat 3: 76-78
72. Purandare SM, Lanyon WG, Arngrimsson R, Connor JM (1995) Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene. Hum Mol Genet 4: 767-768
73. Purandare SM, Lanyon WG, Connor JM (1994) Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet 3: 1109-1115
74. Robinson PN, Boddrich A, Peters H, Tinschert S, Buske A, Kaufmann D, Nurnberg P (1995) Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene. Hum Genet 96: 95-98
75. Roest PA, Roberts RG, Sugino S, van Ommen GJ, den Dunnen JT (1993) Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 2: 1719-1721
76. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-521
77. Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Superneau DW, Martuza RL, Gusella JF (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46: 323-328
78. Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, Gusella JF (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329: 246-248
79. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN (1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54: 45-47
80. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP et al. (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6: 180-184
81. Sainz J, Figueroa K, Baser ME, Mautner VF, Pulst SM (1995) High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Human Molecular Genetics 4: 137-139
82. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994) Mutations in the neurofibromatosis type 2 gene and Jack of the gene product in vestibular shcwannomas. Human Molecular Genetics 3: 885-891
83. Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M, Baron C, Narod S, Delattre O, Lenoir G, Thomas G et al. (1993) Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 2: 1215-1220
84. Sartin EA, Doran SE, Riddell MG, Herrera GA, Tennyson GS, D'Andrea G, Whitley RD, Collins FS (1994) Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans. Am J Pathol 145: 1168-1174
85. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1992) A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 103: 131-143
86. Seizinger BR (1993) NF1: a prevalent cause of tumorigenesis in human cancers? Nature Genetics 3: 97-99
87. Seizinger BR, Rouleau G, Lane AH, Ozelius LJ, Faryniarz AG, Iannazzi J, Hobbs W, Roy JC, Falcone B, Huson S et al. (1987) DNA linkage analysis in Von Recklinghausen neurofibromatosis. J Med Genet 24: 529-530
88. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55: 1227-1231
89. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330: 597-601
90. Skolnick MH, Ponder B, Seizinger B (1987) Linkage of NF1 to 12 chromosome 17 markers: A summary of eight concurrent reprors. Genomics 1: 382-383
91. Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA, Saya H (1994) Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 9: 2135-2144
92. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1994) Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 125: 1371-1384
93. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A (1993) Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet 3: 62-66
94. Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem 269: 23387-23390
95. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K et al. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800
96. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cyroskeletons. J Cell Biol 126: 391-401
97. Tsukita S, Tsukita S (1989) A new 82 kD-barbed end cpping protein localized in the cell-to-cell adherens junctions: purification and characterization. J Cell Biol 108: 2369-2382
98. Turunen O, Wahlstrom T, Vaheri A (1994) Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 126: 1445-1453
99. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3: 147-151
100. Upadhyaya M, Shaw DJ, Harper PS (1994) Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 4: 83-101
101. Valero MC, Velasco E, Moreno F, Hernandez-Chico C (1994) Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE). Hum Mol Genet 3: 639-641
102. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA et al. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62: 187-192
103. von Recklinghausen FD (1882) Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Hirschwatd, Berlin
104. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL et al. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249: 181-186
105. Watson CJ, Gaunt L, Evans G, Patel K, Harris R, Strachan T (1993) A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet 2: 701-704
106. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146: 827-832
107. Wishart J (1822) Cases of tumors in the skull, dura mater and brain. Edingb Med Surg J 18: 393-397
108. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 835-841
109. Xu GF, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CGP, Ponder BAJ (1992) Loss of NF1 alleles in pheochromocytomas from patients with neurofibromatosis type 1. Genes, Chromosomes and Cancer 4: 337-342